RecruitingNot ApplicableNCT06831396

Effectiveness of Ultrasound-Aided Articulation Therapy for Children With Speech Sound Disorders

Communication in Children With or Without Biomedical Conditions: Speech and Language Profile, Related Outcomes and Articulation Treatment With Ultrasound

Sponsor

The University of Hong Kong

Enrollment

60 participants

Start Date

Nov 11, 2023

Study Type

INTERVENTIONAL

Conditions

Speech Sound Disorder

Summary

This prospective randomized controlled trial investigates the effect of ultrasound visual biofeedback as an adjunct to articulation therapy in children with speech sound disorders involving lingual targets. The intervention aims to facilitate acquisition of misarticulated sounds by providing real-time visualization of tongue movements. Participants are randomized 1:1 to immediate treatment or wait-list control, with stratification by disorder type, age, and gender where feasible. The wait-list control group continues usual care for 4 weeks before crossing over to receive the same intervention (ethical crossover design).

Eligibility

Min Age: 5 YearsMax Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Ultrasound-aided articulation therapy for people with speech sound disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 5 Years to 12 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALUltrasound-aided articulation therapy

The intervention under investigation is a motor-phonetic approach to articulation therapy, enhanced with ultrasound visual biofeedback (UVBF). The treatment group will receive the intervention immediately, while the waitlist control group will receive treatment after the initial group completes the study. This design allows for comparative outcome assessments between both groups, ensuring that all participants ultimately receive treatment.